Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows: To compare adverse effects of immunotherapies for people with multiple sclerosis (MS) or clinically isolated syndrome (CIS), and to rank these treatments according to their relative risks of adverse effects.
| Original language | English |
|---|---|
| Article number | CD012186 |
| Journal | Cochrane Database of Systematic Reviews |
| Volume | 2016 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - May 11 2016 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
- Pharmacology (medical)
Cite this
Adverse effects of immunotherapies for multiple sclerosis : A network meta-analysis. / Tramacere, Irene; Benedetti, Maria Donata; Capobussi, Matteo; Castellini, Greta; Citterio, A.; Del Giovane, Cinzia; Frau, Serena; Gonzalez-Lorenzo, Marien; La Mantia, L.; Moja, Pasquale Lorenzo; Nuzzo, Sara; Filippini, Graziella.
In: Cochrane Database of Systematic Reviews, Vol. 2016, No. 5, CD012186, 11.05.2016.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Adverse effects of immunotherapies for multiple sclerosis
T2 - A network meta-analysis
AU - Tramacere, Irene
AU - Benedetti, Maria Donata
AU - Capobussi, Matteo
AU - Castellini, Greta
AU - Citterio, A.
AU - Del Giovane, Cinzia
AU - Frau, Serena
AU - Gonzalez-Lorenzo, Marien
AU - La Mantia, L.
AU - Moja, Pasquale Lorenzo
AU - Nuzzo, Sara
AU - Filippini, Graziella
PY - 2016/5/11
Y1 - 2016/5/11
N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To compare adverse effects of immunotherapies for people with multiple sclerosis (MS) or clinically isolated syndrome (CIS), and to rank these treatments according to their relative risks of adverse effects.
AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To compare adverse effects of immunotherapies for people with multiple sclerosis (MS) or clinically isolated syndrome (CIS), and to rank these treatments according to their relative risks of adverse effects.
UR - http://www.scopus.com/inward/record.url?scp=84966705309&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84966705309&partnerID=8YFLogxK
U2 - 10.1002/14651858.CD012186
DO - 10.1002/14651858.CD012186
M3 - Article
VL - 2016
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
SN - 1361-6137
IS - 5
M1 - CD012186
ER -